Literature DB >> 23630362

Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.

Sunao Sugita1, Yuko Kawazoe, Ayano Imai, Tatsushi Kawaguchi, Shintaro Horie, Hiroshi Keino, Masayo Takahashi, Manabu Mochizuki.   

Abstract

Behçet's disease is a systemic inflammatory disorder with recurrent episodes of oral ulceration, skin lesions, genital ulceration, and intraocular inflammation (uveitis). The intraocular inflammation is strictly associated with Th effector cells. IL-22 is a member of the IL-10 cytokine family that is involved in inflammatory processes. Recently, Th22 cells were identified as a Th cell population that produces IL-22 and TNF-α and are distinct from Th1, Th2, and Th17 cells. In this study, we established Th22-type T cell clones from ocular samples taken from Behçet's disease patients with active uveitis. These clones produced large amounts of IL-22 and TNF-α but not the Th1 cytokine IFN-γ and the Th17 cytokine IL-17. CD4(+) T cells from the peripheral blood of Behçet's disease patients differentiated into Th22 cells in the presence of IL-6 and TNF-α in vitro. The polarized Th22 cell lines produced large amounts of IL-22, and the polarized Th1 and Th17 cells also produced IL-22. In the presence of anti-TNF-α- and anti-IL-6-blocking Abs, Behçet's disease Th22-type T cells failed to produce IL-22. In addition, infliximab-pretreated Th22 cells and Th22-type ocular T cells produced less IL-22 and TNF-α. Moreover, IL-22-producing T cells were isolated from mice with experimental autoimmune uveitis, an animal model of Behçet's disease, and the intraocular T cells from uveitis models produced large amounts of IL-22 in the presence of retinal Ags. Our results suggest that inflammatory cytokines IL-22 and TNF-α may play a key role in the ocular immune response in Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23630362      PMCID: PMC3659956          DOI: 10.4049/jimmunol.1202677

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals.

Authors:  S R Thurau; C C Chan; R B Nussenblatt; R R Caspi
Journal:  Clin Exp Immunol       Date:  1997-08       Impact factor: 4.330

2.  Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.

Authors:  Sunao Sugita; Hiroshi Takase; Chikako Taguchi; Yasuhisa Imai; Koju Kamoi; Tatsushi Kawaguchi; Yoshiharu Sugamoto; Yuri Futagami; Kyogo Itoh; Manabu Mochizuki
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

3.  Gene expression profiling in autoimmune noninfectious uveitis disease.

Authors:  Zhuqing Li; Baoying Liu; Arvydas Maminishkis; Sankaranarayana P Mahesh; Steven Yeh; Julie Lew; Wee Kiak Lim; H Nida Sen; Grace Clarke; Ronald Buggage; Sheldon S Miller; Robert B Nussenblatt
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.

Authors:  S Raziuddin; A al-Dalaan; S Bahabri; A K Siraj; S al-Sedairy
Journal:  J Rheumatol       Date:  1998-02       Impact factor: 4.666

5.  Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.

Authors:  Ilknur Tugal-Tutkun; Abdulbaki Mudun; Meri Urgancioglu; Sevil Kamali; Esen Kasapoglu; Murat Inanc; Ahmet Gül
Journal:  Arthritis Rheum       Date:  2005-08

6.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells.

Authors:  Sara Trifari; Charles D Kaplan; Elise H Tran; Natasha K Crellin; Hergen Spits
Journal:  Nat Immunol       Date:  2009-07-05       Impact factor: 25.606

8.  Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.

Authors:  Wei Chi; Xuefei Zhu; Peizeng Yang; Xiaoli Liu; Xiaomin Lin; Hongyan Zhou; Xiangkun Huang; Aize Kijlstra
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07       Impact factor: 4.799

9.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.

Authors:  Ken Sugimoto; Atsuhiro Ogawa; Emiko Mizoguchi; Yasuyo Shimomura; Akira Andoh; Atul K Bhan; Richard S Blumberg; Ramnik J Xavier; Atsushi Mizoguchi
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

10.  Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.

Authors:  Khalid F Tabbara; Amal I Al-Hemidan
Journal:  Am J Ophthalmol       Date:  2008-10-17       Impact factor: 5.258

View more
  32 in total

Review 1.  Interactions Between the Immune and the Renin-Angiotensin Systems in Hypertension.

Authors:  Nathan P Rudemiller; Steven D Crowley
Journal:  Hypertension       Date:  2016-06-27       Impact factor: 10.190

2.  Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats.

Authors:  Lingjun Zhang; Hui Zheng; Hui Shao; Hong Nian; Yan Zhang; Lingling Bai; Chang Su; Xun Liu; Lijie Dong; Xiaorong Li; Xiaomin Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

3.  Serum IL-33 level and IL-33 gene polymorphisms in Behçet's disease.

Authors:  Suleyman Serdar Koca; Murat Kara; Firat Deniz; Metin Ozgen; Caner Feyzi Demir; Nevin Ilhan; Ahmet Isik
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

Review 4.  Cytokines in uveitis.

Authors:  Jessica E Weinstein; Kathryn L Pepple
Journal:  Curr Opin Ophthalmol       Date:  2018-05       Impact factor: 3.761

Review 5.  T cell subsets: an integral component in pathogenesis of rheumatic heart disease.

Authors:  Devinder Toor; Neha Sharma
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

6.  Interleukin 22 ameliorates neuropathology and protects from central nervous system autoimmunity.

Authors:  Mary J Mattapallil; Jennifer L Kielczewski; Carlos R Zárate-Bladés; Anthony J St Leger; Kumarkrishna Raychaudhuri; Phyllis B Silver; Yingyos Jittayasothorn; Chi-Chao Chan; Rachel R Caspi
Journal:  J Autoimmun       Date:  2019-05-09       Impact factor: 7.094

Review 7.  Interleukin-22: immunobiology and pathology.

Authors:  Jarrod A Dudakov; Alan M Hanash; Marcel R M van den Brink
Journal:  Annu Rev Immunol       Date:  2015-02-11       Impact factor: 28.527

8.  Analysis of Th Cell-related Cytokine Production in Behçet Disease Patients with Uveitis Before and After Infliximab Treatment.

Authors:  Masaru Takeuchi; Yoko Karasawa; Kohzou Harimoto; Atsushi Tanaka; Masaki Shibata; Tomohito Sato; Rachel R Caspi; Masataka Ito
Journal:  Ocul Immunol Inflamm       Date:  2016-04-12       Impact factor: 3.070

9.  Preliminary Report on Interleukin-22, GM-CSF, and IL-17F in the Pathogenesis of Acute Anterior Uveitis.

Authors:  Jerry Chien-Chieh Huang; Matthew Schleisman; Dongseok Choi; Claire Mitchell; Lindsey Watson; Mark Asquith; James T Rosenbaum
Journal:  Ocul Immunol Inflamm       Date:  2019-11-25       Impact factor: 3.070

10.  IL-22 promotes allergic airway inflammation in epicutaneously sensitized mice.

Authors:  Juan Manuel Leyva-Castillo; Juhan Yoon; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2018-06-18       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.